Dde-L-Dap(Fmoc)-OH

Dde-L-Dap(Fmoc)-OH is an orthogonally protected, stereodefined amino acid derivative of L-2,3-diaminopropanoic acid (L-Dap) bearing an Fmoc carbamate on the alpha-amino functionality and an acid-labile Dde (1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl) protecting group on the side-chain amino group. The molecule contains a single chiral center at the amino acid backbone, a protected amine pair suitable for controlled peptide coupling, and a carboxylic acid handle that participates in standard amide bond formation after activation. The orthogonal protecting-group set is designed for stepwise solid-phase or solution-phase peptide assembly, where Fmoc removal can be performed without disturbing the Dde group under typical base conditions, followed by selective Dde deprotection under mild acid to reveal the side-chain amine. The resulting reactivity profile supports iterative peptide synthesis, side-chain functionalization, and downstream conversion into mono- or di-substituted Dap-containing motifs used in peptide science and synthetic methodology.

1. Orthogonal Peptide Synthesis

Dde-L-Dap(Fmoc)-OH is applied in peptide building-block workflows requiring orthogonal protection of diamino acid side chains. The Fmoc group enables controlled N-terminal deprotection for peptide coupling, while the Dde-protected side-chain amine remains masked during Fmoc-based cycles, supporting selective formation of amide bonds without premature side-chain interference. The free carboxylic acid participates in standard peptide coupling chemistry to install the L-Dap residue at a defined position within a growing chain. Stepwise deprotection can expose the side-chain amine for subsequent branching, cyclization, or conjugation steps, enabling construction of Dap-rich peptides and peptidomimetic scaffolds with programmed chemoselectivity. Dde-L-Dap(Fmoc)-OH therefore functions as a structurally tuned intermediate for protected amino acid synthesis and reproducible peptide assembly strategies.

2. Side-Chain Functionalization

Dde-L-Dap(Fmoc)-OH supports chemical biology and synthetic organic chemistry efforts focused on installing functional groups at the Dap side-chain amine. The Dde protecting group provides a masked nucleophile that can be unveiled under acid conditions to generate a reactive primary amine for derivatization, including acylation, sulfonylation, or formation of urea and carbamate linkages. The preserved stereochemistry of the L-Dap backbone helps maintain consistent geometry for downstream molecular recognition studies and structure-activity relationship investigations where stereochemical fidelity is required. The orthogonal protection pattern also allows sequential modification of the side chain after peptide coupling, enabling access to mono-functionalized or selectively crosslinked derivatives. Dde-L-Dap(Fmoc)-OH thus serves as a practical platform for amino acid modification routes that connect protected amino acid chemistry to functional molecule generation.

3. Bioconjugation Linker Chemistry

Dde-L-Dap(Fmoc)-OH is utilized in bioconjugation chemistry to prepare amine-bearing peptide conjugates and modular linkers derived from protected Dap residues. The side-chain amine, once revealed from the Dde group, can participate in conjugation reactions with activated carbonyls, haloacetamides, or other electrophiles used to couple biomolecules and labeling reagents. The Fmoc-protected alpha-amino functionality supports incorporation into peptide carriers, while the orthogonal deprotection strategy helps control where and when the reactive amine is generated during synthesis. L-Dap incorporation can influence local charge density and hydrogen-bonding patterns, which may be relevant for conjugate stability and binding behavior in biochemical assays. Dde-L-Dap(Fmoc)-OH therefore functions as a chiral amino acid intermediate for producing conjugation-ready peptide fragments and downstream biomolecule modification materials.

4. Peptidomimetic And SAR Studies

Dde-L-Dap(Fmoc)-OH is applied in peptidomimetic construction and SAR-focused molecular design where diamino acid motifs are used to tune binding and conformational properties. The compound's protected diamine architecture allows incorporation into peptide analogs with controlled availability of the side-chain nucleophile, supporting systematic variation of substitution patterns on the Dap residue. The carboxylic acid enables peptide coupling to introduce the residue into defined sequences, while the orthogonal protecting-group logic supports iterative synthesis of analog libraries without uncontrolled side reactions. The stereodefined L configuration helps maintain consistent backbone stereochemistry across analog sets, supporting reliable comparison of structure-function relationships. Dde-L-Dap(Fmoc)-OH thereby supports amino acid derivatization workflows that connect protected amino acid synthesis to systematic scaffold generation for medicinal chemistry research.

5. Pharmaceutical Intermediate Preparation

Dde-L-Dap(Fmoc)-OH is suitable for process chemistry and fine chemical synthesis routes that require protected amino acid intermediates for manufacturing peptide-like intermediates. The orthogonal Fmoc/Dde protection strategy aligns with scalable protection-deprotection sequences, where base-mediated Fmoc removal and acid-triggered Dde cleavage can be orchestrated to control functional group exposure. The presence of a carboxylic acid and protected amines enables conversion into activated derivatives for amide formation and subsequent downstream assembly steps in larger synthetic sequences. The controlled chemoselectivity of the diamino acid side chain can reduce impurity formation associated with unprotected polyamine reactivity during intermediate production. Dde-L-Dap(Fmoc)-OH therefore serves as a chiral, protected amino acid intermediate compatible with industrially relevant peptide synthesis planning and specialty chemical production of functional building blocks.

1. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

2. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

3. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)